We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock

Delisted

SRRA was delisted on the 30th of June, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
VC
1
Vivo Capital
California
$30.7M
O
2
OrbiMed
New York
$23.7M
A
3
Abingworth
United Kingdom
$13.9M -$75.2K -5,416 -0.6%
CC
4
Caxton Corporation
New Jersey
$10.3M
RSCM
5
Rock Springs Capital Management
Maryland
$9.1M +$7.88M +567,358 New
NLVP
6
New Leaf Venture Partners
New York
$6.57M
IC
7
Ikarian Capital
Texas
$5.11M +$69.4K +5,000 +2%
FM
8
Frazier Management
Washington
$3.25M
GTC
9
Ghost Tree Capital
New York
$3.21M +$2.78M +200,000 New
6CM
10
683 Capital Management
New York
$2.25M
SCM
11
Silverarc Capital Management
Massachusetts
$2.16M +$1.87M +135,000 New
MP
12
Mangrove Partners
Connecticut
$1.75M -$4.23M -304,895 -74%
Millennium Management
13
Millennium Management
New York
$1.71M -$249K -17,912 -14%
Renaissance Technologies
14
Renaissance Technologies
New York
$1.71M +$79.2K +5,700 +6%
OM
15
Opaleye Management
Massachusetts
$1.21M +$1.05M +75,379 New
PA
16
Perceptive Advisors
New York
$1.07M
SCM
17
Sio Capital Management
New York
$1.06M +$923K +66,455 New
BCM
18
Bridgeway Capital Management
Texas
$861K
BFM
19
Boothbay Fund Management
New York
$618K +$7.85K +565 +1%
Northern Trust
20
Northern Trust
Illinois
$507K -$53.4K -3,842 -11%
TI
21
Telemetry Investments
New York
$358K +$310K +22,349 New
PVI
22
Pura Vida Investments
New York
$304K
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$216K +$3.71K +267 +2%
S
24
SignatureFD
Georgia
$40K -$34.7K -2,500 -50%
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$34K